TVRD
Tvardi Therapeutics, Inc.
$2.02
+0.07 (+3.59%)
At close · Jul 2
Market Cap
$18.95M
Shares
9,381,344
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-09 | Shiff Susan Ph.D. |
Director | Award | 6,000 |
| 2026-06-09 | Shah Sujal |
Director | Award | 6,000 |
| 2026-06-09 | Smith Cynthia |
Director | Award | 6,000 |
| 2026-06-09 | HALL WALLACE L JR |
Director | Award | 6,000 |
| 2026-06-09 | WYZGA MICHAEL S |
Director | Award | 6,000 |
| 2026-01-29 | Conn Avi Daniel |
Chief Financial Officer | Award | 45,000 |
| 2026-01-29 | Kauh John Saewook M.D. |
Chief Medical Officer | Award | 45,000 |
| 2026-01-29 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Award | 115,000 |
| 2026-01-29 | O'Brien Stephen Paul |
Principal Accounting Officer | Award | 15,000 |
| 2025-12-16 | Conn Avi Daniel |
Chief Financial Officer | Award | 17,500 |
| 2025-12-16 | O'Brien Stephen Paul |
Principal Accounting Officer | Award | 4,000 |
| 2025-12-16 | Kauh John Saewook M.D. |
Chief Medical Officer | Award | 17,500 |
| 2025-12-16 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Award | 47,500 |
| 2025-07-07 | Tweardy Samuel David |
10% Owner | Other | 315,658 |
| 2025-07-07 | Tweardy Samuel David |
10% Owner | Other | 315,658 |
| 2025-04-17 | Kauh John Saewook M.D. |
Chief Medical Officer | Award | 36,210 |
| 2025-04-17 | Conn Avi Daniel |
Chief Financial Officer | Award | 43,547 |
| 2025-04-17 | WYZGA MICHAEL S |
Director | Award | 12,000 |
| 2025-04-17 | O'Brien Stephen Paul |
Principal Accounting Officer | Award | 7,213 |
| 2025-04-17 | HALL WALLACE L JR |
Director | Award | 12,000 |
| 2025-04-17 | Shah Sujal |
Director | Award | 12,000 |
| 2025-04-17 | Chen Yixin |
VP, Chem, Mfg and Ctrls | Award | 7,213 |
| 2025-04-17 | Wirk Shaheen |
Director | Award | 12,000 |
| 2025-04-17 | Smith Cynthia |
Director | Award | 12,000 |
| 2025-04-17 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Award | 182,320 |
| 2025-04-17 | Larson Jeffrey Leroy |
SVP, Research & Development | Award | 10,820 |
| 2025-04-17 | Shiff Susan Ph.D. |
Director | Award | 12,000 |
| 2025-04-15 | Smith Cynthia |
Director | Other | 0 |
| 2025-04-15 | Wirk Shaheen |
Director | Other | 0 |
| 2025-04-15 | Larson Jeffrey Leroy |
SVP, Research & Development | Award | 16,764 |
| 2025-04-15 | Chen Yixin |
VP, Chem, Mfg and Ctrls | Other | 0 |
| 2025-04-15 | Shah Sujal |
Director | Other | 0 |
| 2025-04-15 | HALL WALLACE L JR |
Director | Other | 0 |
| 2025-04-15 | O'Brien Stephen Paul |
Principal Accounting Officer | Award | 11,399 |
| 2025-04-15 | Conn Avi Daniel |
Chief Financial Officer | Award | 89,053 |
| 2025-04-15 | Shah Sujal |
Director | Award | 10,394 |
| 2025-04-15 | Wirk Shaheen |
Director | Award | 4,191 |
| 2025-04-15 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Award | 160,940 |
| 2025-04-15 | WYZGA MICHAEL S |
Director | Other | 0 |
| 2025-04-15 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Award | 2,011 |
| 2025-04-15 | HALL WALLACE L JR |
Director | Other | 44,712 |
| 2025-04-15 | Wirk Shaheen |
Director | Award | 2,011 |
| 2025-04-15 | Larson Jeffrey Leroy |
SVP, Research & Development | Award | 5,364 |
| 2025-04-15 | HALL WALLACE L JR |
Director | Other | 202,044 |
| 2025-04-15 | Kauh John Saewook M.D. |
Chief Medical Officer | Other | 0 |
| 2025-04-15 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Other | 0 |
| 2025-04-15 | Wirk Shaheen |
Director | Other | 176,030 |
| 2025-04-15 | Alibhai Imran Nizamudin |
Director, Chief Executive Officer | Award | 207,881 |
| 2025-04-15 | Larson Jeffrey Leroy |
SVP, Research & Development | Other | 0 |
| 2025-04-15 | Chen Yixin |
VP, Chem, Mfg and Ctrls | Award | 14,752 |
Showing 1–50 of 302 transactions